Skip to main content
Caplight Logo









CellDrop Biosciences

CellDrop Biosciences

Private
Laramie, WyomingHealthcare & Life Scienceshttps://www.celldrop.co/

Last Round

Grant

Oct 27, 2023

Total Funding Raised

$1.73M

Company Overview

CellDrop Biosciences is a biotechnology company that develops hydrogel-based encapsulation platforms for scalable, allogeneic stem cell therapies and point-of-care diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

stem cell therapyregenerative medicinecell therapyMSCmesenchymal stem cellhydrogel encapsulationbiomaterial deliveryequine orthopedicsallogeneic therapyveterinary biotechorthopedic treatmentvet medmicrofluidicsoff-the-shelf therapybiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CellDrop Biosciences Comparables

Compare CellDrop Biosciences with similar companies based on industry and business-model similarity.

CellDrop Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Equine Amnio Solutions, LLC
86%
eQcell Inc.
82%
EQGen Biomedical
81%

CellDrop Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 27, 2023
SeedOct 26, 2023
GrantFeb 3, 2021

Key People

Founding team and executive leadership

Ben Noren

CEO & Cofounder

Founding Team

CellDrop Biosciences Investors

Notable investors and investment history

CellDrop Biosciences investors
InvestorRounds
Breakthrough 307Seed
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 12, 2026

    Monthly visitors grew 418% MoM, reaching 803.

  • May 4, 2025

    Monthly visitors increased 705% MoM.

CellDrop Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CellDrop Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CellDrop Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersLaramie, Wyoming
Employee Range2
Year Founded2017
Last FundingOct 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?